Zvada S - Search Results

1

FDA approval summary: Dalteparin for the treatment of symptomatic venous thromboembolism in pediatric patients.

Merino M, Richardson N, Reaman G, Ande A, Zvada S, Liu C, Hariharan S, De Claro RA, Farrell A, Pazdur R. Merino M, et al. Among authors: zvada s. Pediatr Blood Cancer. 2020 Dec;67(12):e28688. doi: 10.1002/pbc.28688. Epub 2020 Sep 8. Pediatr Blood Cancer. 2020. PMID: 32896942

2

Does Hepatic Impairment Affect the Exposure of Monoclonal Antibodies?

Sun Q, Seo S, Zvada S, Liu C, Reynolds K. Sun Q, et al. Among authors: zvada s. Clin Pharmacol Ther. 2020 May;107(5):1256-1262. doi: 10.1002/cpt.1765. Epub 2020 Jan 28. Clin Pharmacol Ther. 2020. PMID: 31899819

3

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.

Jindani A, Harrison TS, Nunn AJ, Phillips PP, Churchyard GJ, Charalambous S, Hatherill M, Geldenhuys H, McIlleron HM, Zvada SP, Mungofa S, Shah NA, Zizhou S, Magweta L, Shepherd J, Nyirenda S, van Dijk JH, Clouting HE, Coleman D, Bateson AL, McHugh TD, Butcher PD, Mitchison DA; RIFAQUIN Trial Team. Jindani A, et al. Among authors: zvada sp. N Engl J Med. 2014 Oct 23;371(17):1599-608. doi: 10.1056/NEJMoa1314210. N Engl J Med. 2014. PMID: 25337749 Free PMC article. Clinical Trial.

4

Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe.

Ngara B, Zvada S, Chawana TD, Nhachi CFB, Rusakaniko S. Ngara B, et al. Among authors: zvada s. BMC Pharmacol Toxicol. 2021 May 24;22(1):29. doi: 10.1186/s40360-021-00497-8. BMC Pharmacol Toxicol. 2021. PMID: 34030726 Free PMC article. Clinical Trial.

5

CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.

Dhoro M, Zvada S, Ngara B, Nhachi C, Kadzirange G, Chonzi P, Masimirembwa C. Dhoro M, et al. Among authors: zvada s. BMC Pharmacol Toxicol. 2015 Mar 27;16:4. doi: 10.1186/s40360-015-0004-2. BMC Pharmacol Toxicol. 2015. PMID: 25889207 Free PMC article.

6

A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents.

Ngara B, Zvada S, Chawana TD, Stray-Pedersen B, Nhachi CFB, Rusakaniko S. Ngara B, et al. Among authors: zvada s. BMC Pharmacol Toxicol. 2020 Aug 3;21(1):58. doi: 10.1186/s40360-020-00437-y. BMC Pharmacol Toxicol. 2020. PMID: 32746923 Free PMC article. Clinical Trial.

7

In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions.

Thelingwani RS, Zvada SP, Dolgos H, Ungell AL, Masimirembwa CM. Thelingwani RS, et al. Among authors: zvada sp. Drug Metab Dispos. 2009 Jun;37(6):1286-94. doi: 10.1124/dmd.108.024604. Epub 2009 Mar 19. Drug Metab Dispos. 2009. PMID: 19299526

8

Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist.

Benichou O, Coskun T, Gonciarz MD, Garhyan P, Adams AC, Du Y, Dunbar JD, Martin JA, Mather KJ, Pickard RT, Reynolds VL, Robins DA, Zvada SP, Emmerson PJ. Benichou O, et al. Among authors: zvada sp. Cell Metab. 2023 Feb 7;35(2):274-286.e10. doi: 10.1016/j.cmet.2022.12.011. Epub 2023 Jan 10. Cell Metab. 2023. PMID: 36630958 Free article.

9

A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine.

Francis J, Zvada SP, Denti P, Hatherill M, Charalambous S, Mungofa S, Dawson R, Dorman S, Gupte N, Wiesner L, Jindani A, Harrison TS, Olagunju A, Egan D, Owen A, McIlleron HM. Francis J, et al. Among authors: zvada sp. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e01964-18. doi: 10.1128/AAC.01964-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670438 Free PMC article. Clinical Trial.

10

Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses.

Zvada SP, Denti P, Donald PR, Schaaf HS, Thee S, Seddon JA, Seifart HI, Smith PJ, McIlleron HM, Simonsson US. Zvada SP, et al. J Antimicrob Chemother. 2014 May;69(5):1339-49. doi: 10.1093/jac/dkt524. Epub 2014 Jan 31. J Antimicrob Chemother. 2014. PMID: 24486870 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters